NYC Healthcare News



NeuroDerm commences enrollment in ND0801 Phase 2a clinical study of ADD/ADHD in adults

December 19, 2015

The PET/CT segment accounted for the largest share - i.e. 97% - of the overall PET market at an estimated $6.1 billion in 2010. This segment is expected to reach $ 9.8 billion in 2015, at a CAGR of 9.8% for the period 2010 to 2015. Oncology and cardiology are the most significant applications of the PET SPECT market. Oncology accounts for about 90% of the PET market, whereas cardiology accounts for about 85% of SPECT application market. Neurological application of PET and SPECT is a niche market and is dependent on the development of appropriate radionuclides and tracers.

Scope of the report

This research report categorizes the global PET SPECT market on the basis of technology, application, and geography; forecasting revenues and analyzing trends in each of the following submarkets:

- On the basis of technology: - Stand alone PET, PET/CT, stand alone SPECT and SPECT/CT - On the basis of application: - Oncology, non small cell lung cancer, Hodgkin and non Hodgkin lymphoma, head and neck cancer, colorectal cancer, breast cancer; cardiology and neurology - On the basis of geography: - U.S., EMEA (Europe, Middle East and Africa), Asia-Pacific and Rest of the world

SOURCE MarketsandMarkets